The interaction of OP449 with SET causes release of SET from PP2A and increases PP2A activity, which was demonstrated in both leukemia cells and some solid tumor cell lines, including MDA-MB-231 (Switzer et al. 2011; Janghorban et al. 2014). Here, PTPA is linked to leukemia.